Heterogeneous chromosome 12p deletion is an independent adverse prognostic factor and resistant to bortezomib-based therapy in multiple myeloma

The deletion of 12p (del(12p)) has been described as a novel negative prognostic marker in multiple myeloma (MM) and has gained increasing attention in recent years. However, its impact on MM is still controversial. In this study, we comprehensively evaluated the clinical impact of 12p13 deletion us...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Li, Fei, Xu, Yan, Deng, Ping, Yang, Ye, Sui, Weiwei, Jin, Fengyan, Hao, Mu, Li, Zengjun, Zang, Meirong, Zhou, Dehui, Gu, Zhimin, Ru, Kun, Wang, Jianxiang, Cheng, Tao, Qiu, Lugui
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2015
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4496228/
https://ncbi.nlm.nih.gov/pubmed/25831238
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak